Tharimmune, Inc. (THAR)
4.37
+0.23
(+5.56%)
USD |
NASDAQ |
Feb 09, 16:00
4.21
-0.16
(-3.66%)
After-Hours: 07:41
Tharimmune Shareholders Equity (Quarterly) : 6.155M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ETHZilla Corp. | 445.14M |
| ACADIA Pharmaceuticals, Inc. | 917.27M |
| Alnylam Pharmaceuticals, Inc. | 233.89M |
| Savara, Inc. | 94.39M |
| BioMarin Pharmaceutical, Inc. | 6.057B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.699M |
| Total Liabilities (Quarterly) | 1.545M |
| Debt to Equity Ratio | 0.0318 |
| Current Ratio | 4.985 |
| Net Debt Paydown Yield | 0.00% |